ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. TLT
9. PMTS
10. QQQ

Go back to ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
(NASDAQ: ZIMV) Delayed: 18.99 --0 (-0%)
Previous Close $18.99    52 Week High $ 
Open $18.99    52 Week Low $ 
Day High $18.99    P/E N/A 
Day Low $18.99    EPS $ 
Volume 14,869